跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,022 条关于
“IMV-001”
全部
18,022
临床试验
9,894
药物
6,307
机构
27
资讯
1,794
9个月前
Imvax Plans FDA Discussions for Glioblastoma Therapy Despite Missing Primary Endpoint
6个月前
Edesa Biotech's Paridiprubart Shows 27% Mortality Reduction in Phase 3 ARDS Study
2年前
Neuraptive's NTX-001 Receives FDA Breakthrough Therapy Designation for Peripheral Nerve Injury
去年
InflaRx's Vilobelimab Receives Positive CHMP Opinion for SARS-CoV-2-Induced ARDS
去年
Insignis Therapeutics Receives Positive FDA Feedback for Needle-Free Anaphylaxis Treatment, IN-001
去年
CD Biopharma's CD-001 Receives FDA Clearance for Phase 1 Trial in Oncology
去年
InflaRx's Vilobelimab Receives Positive CHMP Opinion for COVID-19-Induced ARDS
去年
Hoth Therapeutics' HT-001 Demonstrates 100% Success in Phase 2a Trial for Cancer Treatment Skin Toxicities
去年
Alkeus' Gildeuretinol Receives FDA Rare Pediatric Disease and Fast Track Designations for Stargardt Disease
去年
Neurizon's NUZ-001 Demonstrates Neuroprotective Effects in Huntington's Disease Zebrafish Model
第 1 页,共 180 页
上一页
下一页